基于中西医临床病症特点的肝性脑病动物模型分析
作者单位:

河南中医药大学

基金项目:

河南省重大专项(221100310400); 河南省国际合作重点项目(231111521200);岐黄学者(国中医药人教函2022-6)。


Analysis of an animal model of hepatic encephalopathy based on the characteristics of clinical diseases in Chinese and Western medicine
Author:
Affiliation:

Henan University of Chinese Medicine

  • 摘要
  • | |
  • 访问统计
  • |
  • 参考文献 [72]
  • | | | |
  • 文章评论
    摘要:

    目的:基于中西医临床病症特点对现有的肝性脑病动物模型进行分类、分析,以期为改进和完善现有的肝性脑病动物模型提供思路,以便制备更符合临床特点中西医病症结合肝性脑病动物模型。方法:在中国知网、万方数据库,以“肝性脑病”、“肝昏迷”、“动物”、“动物模型”为关键词,在Pubmed数据库,以“hepatic encephalopathy”、“hepatic coma”、“animal model”、“animal ”为关键词进行检索,整理有具体动物模型制备方法的有效文献,根据不同造模因素和方式进行整理、分类,概括造模方法、特点,依据肝性脑病中西医临床病症特点对动物模型的临床吻合情况进行赋值、分析。结果:有效文献128篇,共11种动物模型,包含15种不同的造模方法,其中,CCl4油溶液模型吻合情况较高,西医吻合度最高的是CCl4油溶液腹腔注射+灌胃+氯化铵腹腔注射模型(吻合度92%),中医吻合度最高的是CCL4油溶液腹腔注射+乙醇水溶液自饮模型(吻合度65%),但缺乏中西医吻合度均同时较高的肝性脑病动物模型。结论:现有的肝性脑病动物模型原理均符合疾病特点,但普遍缺乏中医证候表现,缺乏中西医病症特点结合的动物模型,将中西医临床特点结合制备动物模型,有望为肝性脑病的临床诊治提供模型依据,为中西医结合治疗指明方向。

    Abstract:

    Objective To classify and analyze the existing animal models of hepatic encephalopathy based on the characteristics of Chinese and Western medicine clinical conditions, with a view to providing ideas for improving and perfecting the existing animal models of hepatic encephalopathy, so as to prepare animal models of hepatic encephalopathy that better meet the characteristics of the clinical conditions of Chinese and Western medicine combined with the conditions of hepatic encephalopathy. Methods In China Knowledge Network and Wanfang database, the Keywords "hepatic encephalopathy", "hepatic coma", "animal", "animal model" were used as Keywords, and in Pubmed database, "hepatic encephalopathy", "hepatic coma", " animal model", "animal" as the Keywords to search, collate effective literature with specific animal model preparation methods, collate and classify according to different modeling factors and methods, summarize the modeling methods and characteristics, and assess the clinical match of the animal model based on the characteristics of clinical diseases of hepatic encephalopathy in Chinese and western medicine. The clinical match of the animal model was assigned and analyzed according to the clinical symptoms of hepatic encephalopathy in Chinese and western medicine. Results There were 128 valid literature articles with 11 animal models, including 15 different modeling methods, among which, the CCl4 oil solution model had a high degree of agreement, and the highest degree of agreement in Western medicine was the CCl4 oil solution intraperitoneal injection+gavage+ammonium chloride intraperitoneal injection model (92%), and the highest degree of agreement in traditional Chinese medicine was the CCl4 oil solution intraperitoneal injection+ethanol aqueous solution self-drinking model (65%), but there was a lack of Chinese and Western medicine clinical disease characteristics.Conclusion The existing animal models of hepatic encephalopathy are all in accordance with the characteristics of the disease, but generally lack the manifestation of Chinese medicine, and lack of animal models combining the characteristics of Chinese and Western medicine. Combining the clinical characteristics of Chinese and Western medicine in the preparation of animal models is expected to provide a model basis for clinical diagnosis and treatment of hepatic encephalopathy, and point out the direction for the combination of Chinese and Western medicine in the treatment of hepatic encephalopathy.

    参考文献
    [1] 李建锋,王晓忠.轻微型肝性脑病的中西医诊疗进展[J].中西医结合肝病杂志,2022,32(09):857-860.
    Li JF,Wang XZ. Progress of Chinese and western medicine diagnosis and treatment ofmild hepatic encephalopathy[J]. Journal of Integrated Chinese and Western Medicine and Liver Disease,2022,32(09):857-860.
    [3] [2]徐小元,丁惠国,李文刚,等.肝硬化肝性脑病诊疗指南[J].西南医科大学学报,2018,41(06):477-490.
    Xu XY,Ding HG,Li WG,et al. Guidelines for diagnosis and treatment of hepatic encephalopathy in liver cirrhosis[J]. Journal of Southwest Medical University,2018,41(06):477-490.
    [5] [3]朱荣火,黄晶晶,杜沅沁,等.中医治疗轻微型肝性脑病研究进展[J].西部中医药,2023,36(05):155-157.
    Zhu RH, Huang JJ, Du YQ, et al. Progress in the treatment of mild hepatic encephalopathy by traditional Chinese medicine[J]. Western Traditional Chinese Medicine,2023,36(05):155-157.
    [7] [4]张亮,李浩,汤善宏.肝硬化血氨相关肝性脑病的诊治思考[J].临床肝胆病杂志,2023,39(12):2942-2945.
    Zhang L, Li H, Tang SH. Reflections on the diagnosis and treatment of blood ammonia-related hepatic encephalopathy in liver cirrhosis[J]. Journal of Clinical Hepatobiliary Diseases,2023,39(12):2942-2945.
    [9] [5]乐滢玉,张荣臻,肖伟松,等.肝性脑病发病机制的研究进展[J].中西医结合肝病杂志,2022,32(05):468-472.
    Le YY, Zhang RZ, Xiao WS, et al. Progress in the pathogenesis of hepatic encephalopathy[J]. Journal of Liver Diseases in Chinese and Western Medicine,2022,32(05):468-472.
    [11] [6]Vilstrup H,Amodio P,Bajaj J,et al.Hepatic encephalopathy in chronic liver disease:2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver[J].Hepatology,2014,60(2):715-735.
    [12] [7]Ommati M M, Jamshidzadeh A, Saeed M,et al.. Dextromethorphan improves locomotor activity and decreases brain oxidative stress and inflammation in an animal model of acute liver failure. Clin Exp Hepatol. 2022,8(3):178-187.
    [13] [8]王宪波,时克.肝性脑病的中西医结合诊疗进展与展望[J].临床肝胆病杂志,2022,38(09):1969-1973.
    Wang XB,Shi K. Progress and prospect of integrated diagnosis and treatment of hepatic encephalopathy with Chinese and western medicine[J]. Journal of Clinical Hepatobiliary Diseases,2022,38(09):1969-1973.
    [15] [9]孟书静,张强,苏醒,等.肝硬化患者发生肝性脑病危险因素的Meta分析[J].承德医学院学报,2022,39(04):302-307.
    Meng SJ,Zhang Q,Su X,et al. Meta-analysis of risk factors for hepatic encephalopathy in patients with liver cirrhosis[J]. Journal of Chengde Medical College,2022,39(04):302-307.
    [17] [10]林玉培,王挺帅,刘晓萍,等.中医药调控NF-κB信号通路改善神经炎症防治肝性脑病的研究进展[J].中医学报,2023,38(08):1606-1613.
    Lin YP, Wang TS, LIU Xiaoping, et al. Research progress of Chinese medicine in regulating NF-κB signaling pathway to improve neuroinflammation against hepatic encephalopathy[J]. Journal of Chinese Medicine,2023,38(08):1606-1613.
    [19] [11]石浩,刘永刚,李京涛,等.名中医常占杰从肝-肠-脑论治肝性脑病经验[J].中西医结合肝病杂志,2022,32(07):642-644.
    Shi H, Liu YG, Li JT, et al. Experience of hepatic encephalopathy treated by Chang Zhanjie from liver-gut-brain theory in famous Chinese medicine[J]. Journal of Integrated Chinese and Western Medicine and Liver Disease,2022,32(07):642-644.
    [21] [12]European Association for the Study of the Liver. EASL clinical practice guidelines onthe management of hepatic encephalopathy[J]. J Hepatol,2022,77(3):807?824.
    [22] [13]王天珩,姜彩娥.酒精性肝病伴酒精戒断综合征、高血氨症1例[J].医学理论与实践,2019,32(03):410+426.
    Wang TH,Jiang CE. A case of alcoholic liver disease with alcohol withdrawal syndrome and hyperammonemia[J]. Medical theory and practice,2019,32(03):410+426.
    [24] [14]田硕,曹利华,苗明三,等.基于临床中西医病症特点的中医药动物模型评价新方法[J].中药药理与临床,2017,33(6):165-169.
    Tian S, Cao LH, Miao MS, et al. A new method for evaluating animal models of traditional Chinese medicine based on the characteristics of clinical Chinese and Western medical conditions[J]. Pharmacology and Clinics of Traditional Chinese Medicine,2017,33(6):165-169.
    [26] [15]谭琳玲,潘锦瑶,郑德俊,等.硫代乙酰胺诱导大鼠急性肝性脑病模型建立的用药时间研究[J].现代消化及介入诊疗,2013,18(06):344-348.
    Tan LL, Pan JY, Zheng DJ, et al. Study on the dosing time of thioacetamide-induced acute hepatic encephalopathy model in rats[J]. Modern Digestive and Interventional Diagnosis and Treatment,2013,18(06):344-348.
    [28] [16]吴锐,丁珺,程翅,等.星形胶质细胞参与肝性脑病发病机制的研究[J].中国比较医学杂志,2023,33(03):110-115.
    Wu R, Ding J, Cheng Y, et al. Participation of astrocytes in the pathogenesis of hepatic encephalopathy[J]. Chinese Journal of Comparative Medicine,2023,33(03):110-115.
    [30] [17]唐旭东.实用中医消化病学[M].北京:中国中医药出版社,2022.
    Tang XD. Practical gastroenterology of Chinese medicine [M]. Beijing: China Press of Traditional Chinese Medicine, 2022.
    [32] [18]曹彬.肝性脑病[M].北京:人民卫生出版社,2020.
    Cao B. Hepatic encephalopathy [M]. Beijing:People''s Health Press,2020.
    [34] [19]李亚青,汪小毅,王灿,等.基于中西医临床病症特点的眩晕动物模型分析[J].中国实验动物学报,2024,32(01):92-99.
    Li YQ, Wang XY, Wang C, et al. Analysis of an animal model of vertigo based on the characteristics of Chinese and Western clinical diseases[J]. Chinese Journal of Laboratory Animals,2024,32(01):92-99.
    [36] [20]朱正望,朱平生,苗明三.基于中西医临床病证特点的胆汁淤积性肝病动物模型评价[J].临床肝胆病杂志,2023,39(12):2959-2964.
    Zhu ZW,Zhu PS,Miao MS. Evaluation of an animal model of cholestatic liver disease based on the characteristics of Chinese and Western clinical evidence[J]. Journal of Clinical Hepatobiliary Diseases,2023,39(12):2959-2964.
    [38] [21]苗明三,马林纳,彭孟凡,等.中医药动物模型研究现状[J].中国比较医学杂志,2022,32(01):141-146.
    Miao MS, Ma LN, Peng MF, et al. Current status of research on animal models of traditional Chinese medicine[J]. Chinese Journal of Comparative Medicine,2022,32(01):141-146.
    [40] [22]祝红,黄胜楠,苗明三.口腔溃疡动物模型造模方法及临床吻合度分析[J].世界科学技术-中医药现代化,2023,25(05):1750-1756.
    Zhu H, Huang SN, Miao MS. Analysis of modeling methods and clinical match of animal models of oral ulcer[J]. World Science and Technology-Modernization of Traditional Chinese Medicine,2023,25(05):1750-1756.
    [42] [23]刘冀,朱建忠,隋月林,等.四氯化碳诱导大鼠肝性脑病模型的制备[J].中国比较医学杂志,2012,22(02):33-37.
    Liu J, Zhu JZ, Sui YL, et al. Preparation of carbon tetrachloride-induced hepatic encephalopathy model in rats[J]. Chinese Journal of Comparative Medicine,2012,22(02):33-37.
    [44] [24]田单单,王灿,苗明三.基于中西医临床病证特点的黄疸动物模型分析[J].中药药理与临床,2024,40(01):93-96+128.
    Tian DD, Wang C, Miao MS. Analysis of an animal model of jaundice based on the characteristics of Chinese and Western clinical diseases[J]. Chinese Medicine Pharmacology and Clinic,2024,40(01):93-96+128.
    [46] [25]田单单,王灿,苗明三.基于中西医临床病证特点的脂肪肝动物模型评价[J].世界中医药,2023,18(12):1784-1788.
    Tian DD, Wang C, Miao MS. Evaluation of an animal model of fatty liver based on the characteristics of clinical evidence in Chinese and Western medicine[J]. World TCM,2023,18(12):1784-1788.
    [48] [26]程金来,周子玉,刘丽,等.小鼠急性酒精性肝损伤造模方法的比较[J].中国比较医学杂志,2023,33(07):26-33+40.
    Cheng JL, Zhou ZY, Liu L, et al. Comparison of modeling methods for acute alcoholic liver injury in mice[J]. Chinese Journal of Comparative Medicine,2023,33(07):26-33+40.
    [50] [27]方丽,王静,李雪佩,等.肝性脑病大鼠OXA神经元活性变化及其临床意义研究[J].四川医学,2021,42(10):990-993.
    Fang L, Wang J, Li XP, et al. Changes of OXA neuronal activity and its clinical significance in rats with hepatic encephalopathy[J]. Sichuan Medicine,2021,42(10):990-993.
    [52] [28]陈宜林,周杭,路静,等.隐丹参酮制剂对肝性脑病大鼠的保护作用研究[J].热带医学杂志,2021,21(04):408-412+532.
    Chen YL, Zhou H, Lu J, et al. Study on the protective effect of cryptotanshinone preparation on rats with hepatic encephalopathy[J]. Journal of Tropical Medicine,2021,21(04):408-412+532.
    [54] [29]Simicic D.,Pierzchala K.,Braissant O,et al. P36?Brain Regional Differences in the Developing Brain Using an Animal Model of Type C Hepatic Encephalopathy[J]. The American Journal of Gastroenterology,2023,118(9S).
    [55] [30]Alessandro C D,Luca R,Carlotta M,et al.Possible Association Between DHEA and PKCε in Hepatic Encephalopathy Amelioration:A Pilot Study[J].Frontiers in Veterinary Science,2021,8.
    [56] [31]杜沅沁,王萌,黄国初,等.基于胆汁酸代谢组学探讨复方大黄煎剂保留灌肠对轻微型肝性脑病大鼠模型的治疗作用[J].临床肝胆病杂志,2023,39(10):2348-2357.
    Du YQ,Wang M,Huang GC,et al. Therapeutic effect of compound rhubarb decoction by retention enema in a rat model of mild hepatic encephalopathy based on bile acid metabolomics[J]. Journal of Clinical Hepatobiliary Diseases,2023,39(10):2348-2357.
    [58] [32]廖锦元,黄仲奎,黎宁钦,等.小型猪肝硬化模型肝脏病理及生化指标的变化[J].中国比较医学杂志,2013,23(02):8-11+81-82.
    Liao JY,Huang ZK,Lai NQ,et al. Changes of liver pathology and biochemical indexes in a small pig cirrhosis model[J]. Chinese Journal of Comparative Medicine,2013,23(02):8-11+81-82.
    [60] [33]Mahmoud M S,Elkott A F,Algwaiz H I M,et al.Protective effect of Moringa oleifera Lam.leaf extract against oxidative stress, inflammation,depression,and apoptosis in a mouse model of hepatic encephalopathy.[J].Environmental science and pollution research international,2022,29(55):83783-83796.
    [61] [34]Mireia M,Ramon B,Gemma O,et al.Rat CCl(4)-induced cirrhosis plus total portal vein ligation:a new model for the study of hyperammonaemia and brain oedema.[J].Liver international:official journal of the International Association for the Study of the Liver,2010,30(7):979-87.
    [62] [35]Kazuhiko I,Takeya T ,Aya I, et al.Modulation of duodenal and jejunal microbiota by rifaximin in mice with CClsub4/sub-induced liver fibrosis.[J].Gut pathogens,2023,15(1):14-14.
    [63] [36]李晓娟,朱云,王立福,等.桃核承气汤对大鼠肝性脑病模型干预治疗的分析[J].中国比较医学杂志,2016,26(10):14-18.
    Li XJ, Zhu Y, Wang LF, et al. Analysis of interventional therapy of peach kernel Chengqi Tang on rat hepatic encephalopathy model[J]. Chinese Journal of Comparative Medicine,2016,26(10):14-18.
    [65] [37]李明芳,李曹飞,左东泽,等.肝纤维化的发病机理及相关信号转导机制研究进展[J].中国比较医学杂志,2023,33(08):147-152.
    Li MF, Li CF, Zuo DZ, et al. Progress in the pathogenesis of liver fibrosis and related signaling mechanisms[J]. Chinese Journal of Comparative Medicine,2023,33(08):147-152.
    [67] [38]胡毅龙,赵怡楠,张双丽,等.基于数据挖掘的急性肝损伤动物模型应用分析[J].中国比较医学杂志,2024,34(02):89-100.
    Hu YL, Zhao YN, Zhang SL, et al. Analysis of the application of data mining-based animal model for acute liver injury[J]. Chinese Journal of Comparative Medicine,2024,34(02):89-100.
    [69] [39]周晓玲,王月明,吴腾,等.基于SDF-1/CXCR4轴观察济生肾气汤对肝硬化大鼠BMSCs归巢的影响[J].中国比较医学杂志,2022,32(08):11-18.
    Zhou XL,Wang YM,Wu T, et al. Effects of Jisheng Kidney Qi Tang on homing of BMSCs in cirrhotic rats observed based on SDF-1/CXCR4 axis[J]. Chinese Journal of Comparative Medicine,2022,32(08):11-18.
    [71] [40]田时秋,左泽平,李依林,等.两种大鼠高脂血症模型的特点及性别差异研究[J].中国比较医学杂志,2023,33(03):37-44.
    Tian SQ,Zuo ZP,Li YL,et al. Characteristics of two rat hyperlipidemia models and gender differences[J]. Chinese Journal of Comparative Medicine,2023,33(03):37-44.
    相似文献
    引证文献
    网友评论
    网友评论
    分享到微博
    发 布
引用本文
分享
文章指标
  • 点击次数:93
  • 下载次数: 0
  • HTML阅读次数: 0
  • 引用次数: 0
历史
  • 收稿日期:2024-04-12
  • 最后修改日期:2024-06-03
  • 录用日期:2024-09-30
防诈骗提示!请勿点击不明链接或添加个人微信。编辑部所有邮箱后缀均为@cnilas.org
关闭